Arecor Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprie

Company Highlights
Year Founded

2007

icon-altEmployees

40

Location (HQ)

GBR

Since Last Funding

2 years 3 months

Monthly Website Visitors

8.4K

icon-altTotal Investment Amt

$35M

Last Funding Round

Post Ipo Equity

icon-altYoY Headcount Growth

-9.07%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Pharmaceutical

Education